Amneal Pharmaceuticals, Inc. (AMRX)

13.51 -0.30 (-2.17%) USD  |  NASDAQ  |  Mar 02, 13:11
More

Amneal Pharmaceuticals Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Pfizer Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade